In the control neurologic (MS, NMOSD, OND) cohort, 9 of 15 NMOSD patients harbored AQP4 autoantibodies, and one AQP4 autoantibody–negative patient harbored high-titer (1:36,450) MOG autoantibodies. The gene discussed is AQP4; the disease is myeloid sarcoma.